Research

Jeffrey Rathmell, PhD, directs the Vanderbilt Center for Immunobiology.
July 18, 2019

Center for Immunobiology grows, bolsters program

The Vanderbilt Center for Immunobiology has relaunched its mission with a greater focus on human immunology, an endeavor supported by additional researchers, more funding support and designation as a Center of Excellence.

By Tom Wilemon
Last week’s workshop drew dozens of basement membrane scientists from around the world.
July 18, 2019

Global workshop explores basement membrane research

An international workshop on basement membranes last week attracted about 70 scientists from around the world.

By Bill Snyder
July 16, 2019

A critical factor for wound healing

Vanderbilt-Ingram Cancer Center scientists have discovered a role for a tumor suppressor protein in skin wound healing.

By Anivarya Kumar
July 15, 2019

Potassium balance and glaucoma

Vanderbilt Eye Institute researchers have discovered that an imbalance in the ionic environment of retinal ganglion cells may contribute to functional impairments in glaucoma.

By Sanjay Mishra
July 11, 2019

Vanderbilt team shows how stomach bug can trigger cancer

Researchers at Vanderbilt University and the University of Michigan in Ann Arbor have obtained the first high-resolution image of a molecular “machine” used by the insidious stomach bug Helicobacter pylori (H. pylori) to inject a cancer-causing protein into the stomach lining.

By Bill Snyder
July 11, 2019

New look at atherosclerosis

A new imaging method makes it possible to directly measure cell division and changes in metabolism in atherosclerotic plaques.

By Sanjay Mishra
July 11, 2019

Working memory in psychotic disorders

Functional MRI studies have revealed that targeting activation of certain brain regions may improve working memory and cognition in psychotic disorders.
By Kelsey Herbers
July 9, 2019

Vanderbilt vaccine pioneer James Crowe honored with major science prize

James Crowe Jr., MD, director of the Vanderbilt Vaccine Center, will be honored today by the science and technology company Merck KGaA, Darmstadt, Germany for his contributions to developing new therapeutics and vaccines against some of the world’s deadliest viruses.
By Bill Snyder
July 8, 2019

Clinical study tests drug that may prevent cancer metastasis

A clinical study of a drug that may block cancer metastasis is currently enrolling patients at the Vanderbilt-Ingram Cancer Center.
By Leigh MacMillan
July 2, 2019

Former Pharmacology chair Hardman remembered as gifted scientist, educator, mentor

Joel Hardman, PhD, an internationally recognized scientist and educator who chaired the Department of Pharmacology at Vanderbilt University School of Medicine from 1975 to 1990, died June 30, 2019 in Hoosick Falls, New York, after a lengthy illness. He was 85.
By Bill Snyder
July 1, 2019

Benzodiazepine use with opioids intensifies neonatal abstinence syndrome

Babies born after being exposed to both opioids and benzodiazepines before birth are more likely to have severe drug withdrawal, requiring medications like morphine for treatment, compared to infants exposed to opioids alone.
By Holly Fletcher
June 27, 2019

Health disparity for black people exists within lung screening guidelines

By Tom Wilemon
June 26, 2019

Biomarkers of DNA methylation can be a predictor of breast cancer risk

Biomarkers of DNA methylation, which regulate gene expression, can be a predictor of breast cancer risk.
By Tom Wilemon
1 … 82 83 84 85 86 … 126